Skip navigation
Skip navigation

Cytidine deaminase single-nucleotide polymorphism is predictive of toxicity from gemcitabine in patients with pancreatic cancer: RTOG 9704

Farrell, James; Bae, K.; Wong, J.; Guha, C.; Dicker, Adam; Elsaleh, Hany


The aim of this study is to validate the prognostic and predictive value of the non-synonymous cytidine deaminase (CDA) Lys27 Gln polymorphism for hematological toxicity and survival using a randomized phase III adjuvant trial (Radiation Therapy Oncology

CollectionsANU Research Publications
Date published: 2012
Type: Journal article
Source: Pharmacogenomics Journal
DOI: 10.1038/tpj.2011.22


File Description SizeFormat Image
01_Farrell_Cytidine_deaminase_2012.pdf138.76 kBAdobe PDF    Request a copy
02_Farrell_Cytidine_deaminase_2012.pdf107.82 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator